Novavax, Inc. Detailed Financials

Full historical quarterly statements

Metric2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue139.5M147.1M70.4M239.2M666.7M88.3M84.5M415.5M
Cost of Goods Sold30.7M25.2M21.5M14.2M14.1M36.7M60.6M46.2M
Gross Profit108.8M121.9M48.9M225.0M652.5M51.6M23.9M369.2M
R&D Expenses95.5M74.0M98.3M77.6M88.9M104.4M87.2M106.9M
Operating Expenses124.2M100.9M227.0M119.3M137.0M182.7M157.9M208.2M
Operating Income-15.4M21.0M-178.0M105.7M515.5M-131.1M-134.0M161.0M
Other Income / Gains6.9M-3.1M-25.0M1.8M4.3M57.5M11.7M3.6M
Net Income-9.5M17.5M-202.4M106.5M518.6M-81.0M-121.3M162.4M
EPS (Diluted)-0.060.11-1.250.663.22-0.51-0.761.11
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio0.780.8290.6950.9410.9790.5850.2830.889
General And Administrative Expenses00000000
Selling And Marketing Expenses00000000
Selling General And Administrative Expenses28.8M26.9M31.7M40.6M48.1M78.3M70.7M101.3M
Other Expenses0097.0M1.1M0000
Cost And Expenses154.9M126.1M248.5M133.6M151.1M219.4M218.5M254.5M
Interest Income00000000
Interest Expense-4.9M5.8M5.5M5.5M5.7M7.6M4.2M4.1M
Depreciation And Amortization05.1M6.6M7.6M8.3M12.5M12.7M11.1M
Ebitda-13.4M28.9M-191.0M120.5M533.9M-53.5M-105.4M179.9M
Ebitdaratio-0.0960.196-2.7110.5040.801-0.606-1.2470.433
Operating Income Ratio-0.1110.143-2.5270.4420.773-1.484-1.5860.387
Income Before Tax-8.5M17.9M-203.0M107.5M519.8M-73.6M-122.3M164.6M
Income Before Tax Ratio-0.0610.122-2.8820.4490.78-0.833-1.4480.396
Income Tax Expense985K376K-657K946K1.2M7.4M-1.0M2.2M
Net Income Ratio-0.0680.119-2.8730.4450.778-0.918-1.4350.391
Epsdiluted-0.060.11-1.250.602.93-0.51-0.760.99
Weighted Average Shs Out163.3M162.0M162.4M162.0M161.0M160.2M160.0M148.4M
Weighted Average Shs Out Dil163.3M173.1M162.4M177.2M177.6M160.2M160.0M165.9M